Availability, cost and affordability of essential medicines for smoking cessation in low-income and middle-income countries: a cross-sectional study.

Plum, Catherine, Stolbrink, Marie, Ozoh, Obianuju, Jayasooriya, Shamanthi, Nightingale, Rebecca, Mortimer, Kevin and Halpin, David (2025) 'Availability, cost and affordability of essential medicines for smoking cessation in low-income and middle-income countries: a cross-sectional study.'. Thorax, Vol 80, Issue 4, pp. 248-250.

Text thorax-2024-222391.full.pdf - Published Version Available under License Creative Commons Attribution. Download (447kB)

Abstract

Smoking cessation is more effective when supported by medicines. Data on the availability, cost and affordability of these treatments in low-income and middle-income countries (LMIC) are limited. Cross-sectional data for smoking cessation medications were collected from pharmacies, healthcare facilities and central medicine stores in 60 LMIC (2022–2023). Medications had varying availability, large price ranges and were essentially unaffordable. Enabling access to these medications is important in reducing tobacco consumption and associated disease. Strategies for integrating smoking cessation services into health systems are needed to reach Sustainable Development Goal targets.

Item Type:	Article
Subjects:	QV Pharmacology > Autonomic Agents. Nonmetallic Elements. Neuromuscular Agents > QV 137 Nicotine WA Public Health > WA 30 Socioeconomic factors in public health (General) WA Public Health > Air pollution > WA 754 Pollution and pollutants (incl. tobacco pollution; passive smoking)
Faculty: Department:	Clinical Sciences & International Health > Clinical Sciences Department
Digital Object Identifer (DOI):	https://doi.org/10.1136/thorax-2024-222391
SWORD Depositor:	JISC Pubrouter
Depositing User:	JISC Pubrouter
Date Deposited:	18 Mar 2025 14:26
Last Modified:	20 Mar 2025 13:31
URI:	https://archive.lstmed.ac.uk/id/eprint/26203

Statistics

View details

Actions (login required)

Edit Item